Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

Authors

Institutions

Publication Details

Journal
Circulation Heart Failure
Published
2024-10-18
DOI
https://doi.org/10.1161/circheartfailure.124.011980
Citations
21
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
7.51

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

Kenneth B. Margulies, Silvio E. Inzucchi, Sanjiv J. Shah, Michael J. Muehlbauer et al.
21 citations
Circulation Heart Failure
Diabetes Treatment and Management
7.51
article

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

Kenneth B. Margulies, Silvio E. Inzucchi, Sanjiv J. Shah, Michael J. Muehlbauer, Ali Javaheri, Sheryl L. Windsor, Lydia Coulter Kwee, Robert W. McGarrah, Svati H. Shah, David E. Lanfear, Senthil Selvaraj, Barry A. Borlaug, Andrew J. Sauer, Mansoor Husain, Kavita Sharma, Mikhail Kosiborod, Dalane W. Kitzman, Olga Ilkayeva, Guillermo E. Umpierrez, Christopher B. Newgard, Robert John Mentz, Darren K. McGuire, Philip G. Jones, Shachi Patel
article en
21 citations

Abstract

No abstract available for this paper.
Circulation Heart FailureVol. 17(11)
Northwestern University (US), Parkland Health & Hospital System (US), Mayo Clinic (US), Johns Hopkins University (US), Emory University (US), Duke University (US), Washington University in St. Louis (US), Hospital of the University of Pennsylvania (US), Johns Hopkins Medicine (US), Henry Ford Hospital (US), Yale University (US), Ted Rogers Centre for Heart Research (CA), Mayo Clinic in Arizona (US), Duke Medical Center (US), Saint Luke's Hospital (US), Wake Forest University (US), University of Missouri–Kansas City (US)
U.S. Department of Defense, Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Alnylam Pharmaceuticals, Edwards Lifesciences, Boston Scientific Corporation, Cytokinetics, Dexcom, Tenax Therapeutics, Verily Life Sciences, Novo Nordisk, Vifor Pharma, Esperion Therapeutics, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 2%
Diabetes Treatment and Management
7.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.